ANMOL ARORA: Open Payments
NPI 1487283339 · LA JOLLA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$694 in 23 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $568 · 2025 $694
Food & beverage: $589Education: $104
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 8 | $366 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $133 |
| Alkermes, Inc. | 4 | $85 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| Janssen Pharmaceuticals, Inc | 3 | $53 |
Products named: UZEDY, CAPLYTA, ARISTADA, INVEGA SUSTENNA, ABILIFY ASIMTUFII, REXULTI.
Industry payments across CA — which companies pay providers there.
